BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+23.71%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$403M
AUM Growth
+$403M
(+26%)
Cap. Flow
-$7.62M
Cap. Flow
% of AUM
-1.89%
Top 10 Holdings %
Top 10 Hldgs %
50.05%
Holding
53
New
10
Increased
10
Reduced
12
Closed
14
Top Buys
| 1 |
STAAR Surgical
STAA
|
$16.3M |
| 2 |
Alkermes
ALKS
|
$16M |
| 3 |
QTNT
Quotient Limited Ordinary Shares
QTNT
|
$13.1M |
| 4 |
Lantheus
LNTH
|
$12.7M |
| 5 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$12.4M |
Top Sells
| 1 |
Iovance Biotherapeutics
IOVA
|
$16.5M |
| 2 |
AGN
Allergan plc
AGN
|
$16.2M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$15.7M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$12.9M |
| 5 |
WMGI
Wright Medical Group Inc
WMGI
|
$12.8M |
Sector Composition
| 1 | Healthcare | 86.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BDSI
1
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $27.2M | 3.64% | 4,300,066 | – | – |
|
|
VRAY
2
DELISTED
ViewRay, Inc.
VRAY
| $23.5M | 3.15% | 5,574,366 +2,573,005 | +86% | +$10.9M |
|
|
AMRN
3
Amarin Corp
AMRN
$311M
| $22.5M | 3.01% | 1,049,244 -519,767 | -33% | -$11.1M |
|
|
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $22.3M | 2.98% | 409,338 -123,253 | -23% | -$6.71M |
|
|
5
Alkermes
ALKS
$4.78B
| $21.1M | 2.82% | 1,033,500 +784,500 | +315% | +$16M |
|
|
QTNT
6
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $19M | 2.54% | 1,994,183 +1,380,754 | +225% | +$13.1M |
|
|
EIGR
7
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $18.4M | 2.47% | 1,236,368 -131,009 | -10% | -$1.95M |
|
|
8
STAAR Surgical
STAA
$1.36B
| $16.3M | 2.18% | +462,118 | New | +$16.3M |
|
|
XENT
9
DELISTED
Intersect ENT, Inc
XENT
| $15.7M | 2.1% | 631,023 -148,111 | -19% | -$3.69M |
|
|
PGNX
10
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $15.6M | 2.09% | 3,060,923 +1,476,998 | +93% | +$7.52M |
|
|
NSTG
11
DELISTED
NanoString Technologies, Inc.
NSTG
| $15.5M | 2.07% | 555,600 +444,800 | +401% | +$12.4M |
|
|
12
Iovance Biotherapeutics
IOVA
$807M
| $14.8M | 1.98% | 533,301 -597,800 | -53% | -$16.5M |
|
|
DERM
13
DELISTED
Dermira, Inc.
DERM
| $13.6M | 1.82% | 896,334 +316,734 | +55% | +$4.8M |
|
|
SCTL
14
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $13.2M | 1.77% | 721,073 -266,687 | -27% | -$4.89M |
|
|
15
Lantheus
LNTH
$3.73B
| $12.7M | 1.7% | +617,953 | New | +$12.7M |
|
|
VAPO
16
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $12.2M | 1.63% | +1,003,099 | New | +$12.2M |
|
|
SIEN
17
DELISTED
Sientra, Inc.
SIEN
| $11.5M | 1.54% | 1,286,987 -714,908 | -36% | -$6.39M |
|
18
Vericel Corp
VCEL
$1.83B
| $10.8M | 1.44% | 620,199 +383,149 | +162% | +$6.67M |
|
|
LJPC
19
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $10.6M | 1.41% | 2,688,068 +2,506,224 | +1,378% | +$9.85M |
|
|
ALXN
20
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $8.99M | 1.2% | +83,100 | New | +$8.99M |
|
21
Sol-Gel Technologies
SLGL
$63.5M
| $8.95M | 1.2% | 521,819 -41,481 | -7% | -$711K |
|
22
Relmada Therapeutics
RLMD
$37.2M
| $8.61M | 1.15% | +220,724 | New | +$8.61M |
|
23
Aurinia Pharmaceuticals
AUPH
$1.58B
| $8.1M | 1.09% | +400,000 | New | +$8.1M |
|
|
AVDL
24
Avadel Pharmaceuticals
AVDL
$1.43B
| $7.77M | 1.04% | 1,029,012 -2,073,661 | -67% | -$15.7M |
|
25
Exicure
XCUR
$35.4M
| $7.74M | 1.04% | 2,707,851 +395,945 | +17% | +$1.13M |
|